Report Categories
View AllRecent Articles
View All
What the market is pricing into REGENXBIO RGNX ahead of earnings Q4 2025 Profit Disappoints
What VivoSim Labs VIVS capital allocation tells us Q3 2025 Better Than Expected
PYXS Pyxis Oncology beats Q4 2025 loss estimates but shares shed 235 percent amid weak investor reaction
US February PPI and Residential Construction Input Cost Trends Analysis
CZR Q1 2026 Earnings Deep EPS Miss Overshadows Modest Share Gains
Hennessy Advisors Inc HNNA Q1 2026 Earnings EPS of 024 Amid Flat Revenue and Negative Market Reaction
Xi Jinping Reaffirms Commitment to Opening Chinas Economy to US Firms During Trump Visit
HIVE Stock Advances Following Cantor Fitzgeralds Price Target Revision
HLX Q1 2026 Earnings Earnings Miss Weighs on Shares as Helix Energy Posts WiderThanExpected Loss
JOE Q1 2026 Earnings EPS of 024 Meets Expectations Stock Declines Slightly